Invisio AB (publ)

Stockholm Stock Exchange IVSO.ST

Invisio AB (publ) EBT Margin for the year ending December 31, 2023: 19.53%

Invisio AB (publ) EBT Margin is 19.53% for the year ending December 31, 2023, a 142.35% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.
  • Invisio AB (publ) EBT Margin for the year ending December 31, 2022 was 8.06%, a 103.37% change year over year.
  • Invisio AB (publ) EBT Margin for the year ending December 31, 2021 was 3.96%, a -75.17% change year over year.
  • Invisio AB (publ) EBT Margin for the year ending December 31, 2020 was 15.96%, a -38.85% change year over year.
  • Invisio AB (publ) EBT Margin for the year ending December 31, 2019 was 26.10%, a 44.12% change year over year.
Key data
Date EBT Margin Net Income Margin EBITDA Margin EBIT Margin
Market news
Loading...
SV Wall Street
Stockholm Stock Exchange: IVSO.ST

Invisio AB (publ)

CEO Mr. Lars Hojgard Hansen
IPO Date June 11, 2008
Location Sweden
Headquarters PO Box 151
Employees 274
Sector Consumer Discretionary
Industries
Description

Invisio AB (publ) develops and sells personal communication and hearing protection systems for professionals in the defense and military, law enforcement, and security sectors in Sweden, Europe, North America, and internationally. The company offers headsets, control units, intercom systems, accessories and remote push-to-talk units, and cables. Its products are used in high noise and hearing protection applications. The company sells its products under the INVISIO, and Racal Acoustics brands. Invisio AB (publ) markets and sells its products through partners and resellers. The company was formerly known as INVISIO Communications AB (publ) and changed its name to Invisio AB (publ) in June 2010. Invisio AB (publ) was founded in 1999 and is based in Malmö, Sweden.

Similar companies

HTRO.ST

Hexatronic Group AB (publ)

USD 3.11

-4.78%

XVIVO.ST

Xvivo Perfusion AB (publ)

USD 41.47

-0.80%

MYCR.ST

Mycronic AB (publ)

USD 39.13

-3.14%

SECT-B.ST

Sectra AB (publ)

USD 22.49

-1.31%

CEVI.ST

CellaVision AB (publ)

USD 19.20

-5.48%

StockViz Staff

February 5, 2025

Any question? Send us an email